Clinical Trials Extraction Research and Development 
Cannabis Law Report
JUNE 29, 2021
Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. ” About Ehave, Inc. Ehave, Inc. Email: ir@ehave.com.
Cannabis Law Report
AUGUST 5, 2021
NEO:FH , Forum ), an exclusively natural psychedelic drug development company. To support its mission, the company has a robust portfolio of extraction and purification methods, a botanical extraction management team, a Health Canada psilocybin Dealer’s License, and in-house GMP manufacturing capabilities. Investment summary.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JULY 1, 2022
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
Cannabis Law Report
JUNE 7, 2021
Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Industry Developments.
Cannabis Law Report
JULY 24, 2021
At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer. “At At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer.
Project CBD
NOVEMBER 11, 2023
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Cannabis Law Report
AUGUST 9, 2021
Investors will continue to keep an eye on several ongoing clinical trials, as well as private companies that are gearing up to go public over the coming quarters. OTC: WUHN) recently announced that a research team funded by the company successfully published a third paper on the Dovepress platform. Industry Developments.
Expert insights. Personalized for you.
105 
Let's personalize your content